Required fields are marked with *
An intermediate in the synthesis of Semaglutide, an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes.
CAT NO. : BAT-006233
CAT NO. : BAT-006155
CAT NO. : BAT-006230
CAT NO. : BAT-006225
CAT NO. : BAT-006245
CAT NO. : BAT-000828